{
     "PMID": "3002517",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19860306",
     "LR": "20141120",
     "IS": "0365-9615 (Print) 0365-9615 (Linking)",
     "VI": "101",
     "IP": "1",
     "DP": "1986 Jan",
     "TI": "[Interaction of piracetam with 3H-imipramine binding sites and the GAMA-benzodiazepine receptor complex of brain membranes].",
     "PG": "40-2",
     "AB": "Piracetam at a concentration of 10(-6) M was shown to behave as a noncompetitive inhibitor of 3H-imipramine specific binding to rat brain membranes. At the same time piracetam failed to influence specific binding of 3H-mianserin to membranes of guinea-pig cerebellum, which is indicative of its inability to suppress histamine H1 receptors, a component of 3H-imipramine specific binding sites. At a concentration of 10(-4) M piracetam does not change specific binding of 3H-flunitrazepam to rat hippocampal membranes in the absence of GABA, but in the presence of 5 X 10(-5) M GABA, like atypical tranquilizer mebicar, acts as a competitor of 3H-flunitrasepam binding. Though Ro-15 1788 did not suppress anxyolytic piracetam (and mebicar) effect, our results give evidence of a possible involvement of GABA-benzodiazepine supramolecular complex in the anxiolytic activity of piracetam.",
     "FAU": [
          "Rozhanets, V V",
          "Chakhbra, K K",
          "Danchev, N D",
          "Malin, K M",
          "Rusakov, D Iu"
     ],
     "AU": [
          "Rozhanets VV",
          "Chakhbra KK",
          "Danchev ND",
          "Malin KM",
          "Rusakov DIu"
     ],
     "LA": [
          "rus"
     ],
     "PT": [
          "English Abstract",
          "Journal Article"
     ],
     "TT": "Vzaimodeistvie piratsetama s mestami spetsificheskogo sviazyvaniia 3H-imipramina i GAMK-benzodiazepinovym retseptornym kompleksom membran golovnogo mozga.",
     "PL": "Russia (Federation)",
     "TA": "Biull Eksp Biol Med",
     "JT": "Biulleten' eksperimental'noi biologii i meditsiny",
     "JID": "0370627",
     "RN": [
          "0 (Carrier Proteins)",
          "0 (Pyrrolidinones)",
          "0 (Receptors, Drug)",
          "0 (Receptors, GABA-A)",
          "0 (Receptors, Neurotransmitter)",
          "0 (imipramine receptor)",
          "OGG85SX4E4 (Imipramine)",
          "ZH516LNZ10 (Piracetam)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Binding, Competitive",
          "Brain/*metabolism",
          "*Carrier Proteins",
          "Cerebellum/metabolism",
          "Guinea Pigs",
          "Hippocampus/metabolism",
          "Imipramine/*metabolism",
          "In Vitro Techniques",
          "Male",
          "Membranes/metabolism",
          "Piracetam/*metabolism/pharmacology",
          "Pyrrolidinones/*metabolism",
          "Rats",
          "*Receptors, Drug",
          "Receptors, GABA-A/*metabolism",
          "Receptors, Neurotransmitter/*metabolism"
     ],
     "EDAT": "1986/01/01 00:00",
     "MHDA": "1986/01/01 00:01",
     "CRDT": [
          "1986/01/01 00:00"
     ],
     "PHST": [
          "1986/01/01 00:00 [pubmed]",
          "1986/01/01 00:01 [medline]",
          "1986/01/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Biull Eksp Biol Med. 1986 Jan;101(1):40-2.",
     "term": "hippocampus"
}